ArticleJPRAS open2026
Impact of body mass index on surgical outcomes and delay adjuvant treatment in patients undergoing therapeutic mammoplasty for breast cancer.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Therapeutic mammoplasty (TM) is an oncoplastic technique that combine wide excision of cancer with breast reduction, enabling breast conservation in patients with moderate-to-large breasts. The effect of body mass index (BMI) on TM and oncological outcomes remains controversial. This study aims to evaluate the complication rate in high BMI patients undergoing TM and to assess the impact on timing of adjuvant therapy. Patients and methods: Retrospective review of patients underwent TM between January 2014 and January 2024. Data recorded include age, weight, height, BMI, smoking, comorbidities, tumor type and size, lymph node status, neoadjuvant / adjuvant treatment and its timing. Surgery performed by one surgeon. All patients had contralateral reduction at the same session. Type of pedicle, weight of removed breast tissue, and postoperative complications were recorded. Statistical analysis was performed using the appropriate statistical test. Results: About 73 patients were included in the analysis. Patient's mean age was 61 years (range: 58-67), Mean BMI 29.1 kg/m² (range: 20-43). The average weight of tissue removed per breast was 653 g (range: 219-948 g). Overall complications rate (32.8 %). Two patients returned to theatre for drainage of hematoma (2.7%) and the remaining minor wound complications were treated as outpatient. About 45 patients (61.6%) had BMI < 30 with 15 patients developed wound complication (33%). 28 patients (38.4%) had BMI ≥ 30 with nine patients developed wound complications (32%) Conclusions: TM is a safe technique for breast cancer surgery. According to our experience, patients with high BMI (>30 kg/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.